NHS Tayside have signed a five-year agreement with Alcidion to implement Miya Observations and Assessments (Miya Observations), an electronic monitoring system that will help thousands of busy healthcare professionals as they care for patients. NHS Tayside are the third health board in Scotland to implement Miya Observations, continuing to validate the benefits of our products in the United Kingdom.
Formerly known as Patientrack, the system has already delivered substantial clinical benefits in other NHS hospitals, including early adopters in Scotland, where alerts provided by the system and improved visibility of the sickest patients, have helped staff to significantly enhance patient safety and cut cardiac arrests.
NHS Tayside, which employs 14,000 people and serves a population of more than 400,000 across rural and urban communities in Dundee City, Angus and Perth and Kinross, will deploy Miya Observations throughout its regional network.
Miya Observations provides an early warning system that shares critical information as soon as it is recorded, rather than simply passively capturing a patient’s vital signs on a paper-based bedside chart. The system alerts clinical staff when patients show signs of deterioration, so healthcare professionals can rapidly intervene and focus on those patients immediately in need. It has helped hospitals to prevent negative clinical outcomes and to manage risks around deadly conditions including acute kidney injury and sepsis. Hospitals using the system have observed reduced length of stay and many other benefits.
NHS Tayside will use Miya Observations across approximately 975 beds to electronically record vital signs and patient observations, produce charts, automatically calculate patient early warning scores, generate clinical alerts, and document a range of clinical assessments.
Alcidion UK Commercial Director Tom Scott said, “We are thrilled to be partnering with NHS Tayside, extending Miya Observations to a third health board in Scotland. This agreement represents recognition of the benefits that are realised through capturing key clinical data at the bedside and reporting and acting on it in real time”.
Alcidion Group Managing Director Kate Quirke noted, “Healthcare technology should exist to deliver benefits to the people delivering and receiving care. It should help to make the right thing to do the easiest thing to do. I look forward to seeing these benefits extend to healthcare professionals and patients in NHS Tayside as the health board deploys Alcidion’s Miya capabilities. It is rewarding to see this success story continue to grow in Scotland, and to be welcoming another important NHS customer in the UK”.